Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load, and lessening inflammation


Autoria(s): TSUHAKO, Maria Heloisa; AUGUSTO, Ohara; LINARES, Edlaine; CHADI, Gerson; GIORGIO, Selma; PEREIRA, Carlos A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Multiple sclerosis (MS) is a progressive inflammatory and/or demyelinating disease of the human central nervous system (CNS). Most of the knowledge about the pathogenesis of MS has been derived from murine models, such as experimental autoimmune encephalomyelitis and vital encephalomyelitis. Here, we infected female C57BL/6 mice with a neurotropic strain of the mouse hepatitis virus (MHV-59A) to evaluate whether treatment with the multifunctional antioxidant tempol (4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy) affects the ensuing encephalomyelitis. In untreated animals, neurological symptoms developed quickly: 90% of infected mice died 10 days after virus inoculation and the few survivors presented neurological deficits. Treatment with tempol (24 mg/kg, ip, two doses on the first day and daily doses for 7 days plus 2 mM tempol in the drinking water ad libitum) profoundly altered the disease outcome: neurological symptoms were attenuated, mouse survival increased up to 70%, and half of the survivors behaved as normal mice. Not Surprisingly, tempol substantially preserved the integrity of the CNS, including the blood-brain barrier. Furthermore, treatment with tempol decreased CNS vital titers, macrophage and T lymphocyte infiltration, and levels of markers of inflammation, such as expression of inducible nitric oxide synthase, transcription of tumor necrosis factor-alpha and interferon-gamma, and protein nitration. The results indicate that tempol ameliorates murine viral encephalomyelitis by altering the redox status of the infectious environment that contributes to an attenuated CNS inflammatory response. overall, our study supports the development of therapeutic strategies based on nitroxides to manage neuroinflammatory diseases, including MS. (C) 2009 Elsevier Inc. All rights reserved.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

FREE RADICAL BIOLOGY AND MEDICINE, v.48, n.5, p.704-712, 2010

0891-5849

http://producao.usp.br/handle/BDPI/30993

10.1016/j.freeradbiomed.2009.12.013

http://dx.doi.org/10.1016/j.freeradbiomed.2009.12.013

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

Relação

Free Radical Biology and Medicine

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #Multiple sclerosis #Encephalomyelitis #Mouse hepatitis virus #Tempol #Antioxidant #Anti-inflammatory #Inflammation #Redox status #Nitric oxide-derived oxidants #Free radicals #MOUSE HEPATITIS-VIRUS #EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS #EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS #PROTEIN-TYROSINE NITRATION #CENTRAL-NERVOUS-SYSTEM #NITRIC-OXIDE #MULTIPLE-SCLEROSIS #IN-VIVO #URIC-ACID #CARBONATE RADICALS #Biochemistry & Molecular Biology #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion